Expression of Phosphorylated Histone H2AX (γ-H2AX) in Normal and Neoplastic Squamous Epithelia of the Uterine Cervix: An Immunohistochemical Study With Epidermal Growth Factor Receptor

被引:15
作者
Brustmann, Hermann [1 ]
Hinterholzer, Susanne [2 ]
Brunner, Andreas [2 ]
机构
[1] Landesklinikum Thermenreg Moedling, Dept Pathol, A-2340 Modling, Austria
[2] Landesklinikum Thermenreg Moedling, Dept Obstet & Gynecol, A-2340 Modling, Austria
关键词
gamma-H2AX; EGFR; CIN; Squamous cell carcinoma; Cervix uteri; DNA-DAMAGE; INTRAEPITHELIAL NEOPLASIA; CANCER; LESIONS; REPAIR; CARCINOMAS; ARREST; CELLS; CIN;
D O I
10.1097/PGP.0b013e3181eb2fcb
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
The histone gamma-H2AX is a marker of activated DNA damage and is overexpressed in different cancers and their precursor lesions, indicating a role in oncogenic transformation. Epidermal growth factor receptor (EGFR) is overexpressed in many kinds of epithelial neoplasms. This study aimed to determine whether immunohistochemical expression of gamma-H2AX is involved in the progression of the morphological spectrum from normal squamous cervical epithelia (NE, n = 33) to cervical intraepithelial neoplasia (CIN; CIN1, n = 9; CIN2/3, n = 33) and cervical invasive squamous cell carcinoma (ISCC, n = 33), whether g-H2AX expression follows the pattern of proliferation of atypical squamous cells as shown by EGFR immunoreactivity, and whether it is correlated with clinicopathologic variables in ISCC. Immunostaining for both the factors was scored semiquantitatively for moderate and strong intensities. Gamma-H2AX and EGFR expression, respectively, increased from NE and CIN1 to CIN2/3 and ISCCs significantly (P = 0.0001, respectively). Gamma-H2AX reactivity was found in the nuclei of the cells of the upper epithelial levels and the cells of basal/parabasal type in variable quantities in NE and CIN; expression of gamma-H2AX was seen in the nuclei of ISCC including keratinizing cells in horn pearls. EGFR staining was mainly membranous and noted in basal/parabasal cells in NE and atypically proliferating keratinocytes in CIN and nonkeratinizing cells of ISCC. In addition, immature squamous metaplasias were decorated by the antibodies used. Immunoscores for gamma-H2AX and EGFR, respectively, did not differ between International Federation of Gynecology and Obstetrics stages I and II, keratinizing and nonkeratinizing ISCC, and CIN2/3 and ISCC. However, expression patterns were different for both the factors, suggesting their involvement in different biological mechanisms, with regard to gamma-H2AX apart from proliferation. Overexpression of gamma-H2AX in CIN2/3 and ISCC of the uterine cervix reflects the neoplastic transformation of cervical squamous epithelia in reaction to increased DNA-damage and supports the classification of dysplasia into low-grade squamous intraepithelial lesions and high-grade squamous intraepithelial lesions.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 26 条
[1]
Alvarez G, 2006, MODERN PATHOL, V19, p101A
[2]
Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas [J].
Baltazar, Fatima ;
Longatto Filho, Adhemar ;
Pinheiro, Celine ;
Moreira, Marise A. R. ;
Silva Queiroz, Geraldo ;
Bittar Oton, Gloria Jabur ;
Fraga Junior, Ailton ;
Jube Ribeiro, Luiz Fernando ;
Schmitt, Fernando C. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2007, 26 (03) :235-241
[3]
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[4]
Overexpression of epidermal growth factor type-l receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease [J].
Bellone, Stefania ;
Frera, Glanluca ;
Landolfi, Gianpiero ;
Romani, Chiara ;
Bandiera, Efisabetta ;
Tognon, Gen-Nana ;
Roman, Juan J. ;
Burnett, Alexander F. ;
Pecorelli, Sergio ;
Santin, Alessandro D. .
GYNECOLOGIC ONCOLOGY, 2007, 106 (03) :513-520
[5]
Boiko IV, 1998, CLIN CANCER RES, V4, P1383
[6]
OPINION γH2AX and cancer [J].
Bonner, William M. ;
Redon, Christophe E. ;
Dickey, Jennifer S. ;
Nakamura, Asako J. ;
Sedelnikova, Olga A. ;
Solier, Stephanie ;
Pommier, Yves .
NATURE REVIEWS CANCER, 2008, 8 (12) :957-967
[7]
Epidermal growth factor receptor is involved in the development of an invasive phenotype in Vulvar squamous lesions, but is not related to MIB-1 immunoreactivity [J].
Brustmann, Hermann .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2007, 26 (04) :481-489
[8]
Clinical experience with monoclonal antibodies to epidermal growth factor receptor [J].
Calvo E. ;
Rowinsky E.K. .
Current Oncology Reports, 2005, 7 (2) :96-103
[9]
EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AND THE PRESENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS [J].
CHAPMAN, WB ;
LORINCZ, AT ;
WILLETT, GD ;
WRIGHT, VC ;
KURMAN, RJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1992, 11 (03) :221-226
[10]
CLIFFORD GM, 2006, VACCINE